Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 41

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04992520Phase 1Completed
Controlled Human Infection Model Challenge/Rechallenge
Shigellosis
PrincipalinvestigatorStart date: 2022-04-26
NCT05028361Phase 4Completed
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
Adverse Drug EventInjection Site ReactionQuality of Life+1 more
PrincipalinvestigatorStart date: 2021-10-04

Research Network

Collaboration Network

12 collaborators·14 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Emmanuel B Walter, MD, MPH

Duke University

Moderately Similar
3 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse ReactionsInjection Site ReactionQuality of Life+1 more

Worked with same sponsors:

Centers for Disease Control and PreventionChildren's Hospital Medical Center, Cincinnati+2 more
Collaborated on 1 trial
Similarity Score44%

Elizabeth Schlaudecker, MD, MPH

Children's Hospital Medical Center, Cincinnati

Moderately Similar
1 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse ReactionsInjection Site ReactionQuality of Life+1 more

Worked with same sponsors:

Centers for Disease Control and PreventionChildren's Hospital Medical Center, Cincinnati+2 more
Collaborated on 1 trial
Similarity Score44%

Karen R Broder, MD

Centers for Disease Control and Prevention

Moderately Similar
5 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse ReactionsInjection Site ReactionQuality of Life+1 more

Worked with same sponsors:

Centers for Disease Control and PreventionChildren's Hospital Medical Center, Cincinnati+2 more
Collaborated on 1 trial
Similarity Score44%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Quality of LifeDrug-Related Side Effects and Adverse Reactions
Similarity Score12%

Olivier Beauchet, MD

Jewish General Hospital

Related
19 trials

Shared therapeutic areas:

Quality of Life
Similarity Score6%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Quality of Life
Similarity Score6%

Michael S Avidan, MBBcH

Washington University School of Medicine

Related
10 trials

Shared therapeutic areas:

Quality of Life
Similarity Score6%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Quality of Life

Worked with same sponsors:

Duke University
Similarity Score6%

Tai hing Lam, MD

The University of Hong Kong

Related
10 trials

Shared therapeutic areas:

Quality of Life
Similarity Score6%

Ho-Hsiung Lin, PhD

National Taiwan University Hospital

Related
15 trials

Shared therapeutic areas:

Quality of Life
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04992520Phase 1PrincipalInvestigator

Controlled Human Infection Model Challenge/Rechallenge

Shigellosis
Completed
NCT05028361Phase 4PrincipalInvestigator

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

Adverse Drug EventInjection Site ReactionQuality of Life+1 more
Completed

All 2 trials loaded